Animal Free Structured Collagens for Regenerative Medicine
Animal Free Structured Collagens for Regenerative Medicine
批准号:
10076142
负责人:
金额:
$6.28万
依托单位:
依托单位国家:
英国
项目类别:
Grant for R&D
财政年份:
2023
资助国家:
英国
项目状态:
已结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Collagen is the protein 'cement' material that occurs between and binds cells in connective tissues (e.g., muscles, bones, skin) and organs in both humans and animals. As a resource, types of collagen can be extracted from animal products (e.g., cow skin) or as in the case of this project it is possible to synthesize them by incorporating the genes for human collagen into yeast. The pharmaceutical industry uses such an approach for the production of human insulin from bacteria for the treatment of diabetes. Producing collagen as a product of yeast fermentation is advantageous as it removes the risks inherent to animal products such as viruses and prions; provides a purer raw material free of potentially difficult to remove contaminants; and is suitable for Vegan classification.The purpose of this project is to optimise a process method that has already been successfully demonstrated for human Type I collagen production and apply this to two different forms of human collagen, Type II and Type III, which are found in different tissues of the body. Small scale trials have shown that yeast cells can be grown and sustained in a fixed volume tank where they are fed continuously such that they are able to produce human collagen in the form of Type 1\. This product is then separated from the main fermenter stock for downstream processing and preparation for sale. ProColl have successfully achieved this for Type 1 collagen, we are now seeking funds to develop processes to produce Type II and Type III human collagens. These three collagens (Type I, II, III) make up 99% of all types of collagens found in the body by volume, and so the ability to manufacture all of them from non-animal sources would be of great benefit for medical research and medical device industries which are seeking more biocompatible, safer, and ethical-free sources of collagen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
一次扫描多对比度及free-water DTI技术在功能区脑肿瘤中的研究
-
批准号:JCZRLH202500011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于碳纳米管技术和转座子开发一种新型的、
marker-free 的植物转基因技术
-
批准号:Z24C160005
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周明兵
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
基于Lab-free电化学发光平台的ctDNA甲基化分析研究
-
批准号:22374123
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:卓颖
-
依托单位:
基于制备内源5mc-free基因组的策略鉴定新型DNA修饰并解析其产生机理
-
批准号:32370576
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:陈辉
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
利用CRISPR/Cas RNP介导的DNA-free基因编辑衣藻控制登革热传播媒介伊蚊
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:35万元
-
批准年份:2022
-
负责人:费小雯
-
依托单位:
番茄基于DNA-free基因编辑技术的2种类病毒抑制和脱毒的机理研究
-
批准号:32102396
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李经纬
-
依托单位:
低损耗snapback-free RC LIGBT机理与新结构研究
-
批准号:62104030
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2021
-
负责人:杨可萌
-
依托单位: